Current reading list (November 2022)

We have been keeping an eye on the methods literature, and think people with an interest in the Bias Methods Group may be interested in the following articles published recently:

Clark L, Burke L, Margaret Carr R, Coleman E, Roberts G, Torgerson DJ. A review found small variable blocking schemes may not protect against selection bias in randomized controlled trials. J Clin Epidemiol 2022;141:90-8.

Fanelli D, Wong J, Moher D. What difference might retractions make? An estimate of the potential epistemic cost of retractions on meta-analyses. Account Res 2022;29:442-59.

Frost AD, Hróbjartsson A, Nejstgaard CH. Adherence to the PRISMA-P 2015 reporting guideline was inadequate in systematic review protocols. J Clin Epidemiol 2022;150:179-87.

Hackenbroich S, Kranke P, Meybohm P, Weibel S. Include or not to include conference abstracts in systematic reviews? Lessons learned from a large Cochrane network meta-analysis including 585 trials. Syst Rev 2022;11:178.

Iflaifel M, Partlett C, Bell J, Cook A, Gamble C, Julious S, et al. Blinding of study statisticians in clinical trials: a qualitative study in UK clinical trials units. Trials 2022;23:535.

Jankowski S, Boutron I, Clarke M. Influence of the statistical significance of results and spin on readers' interpretation of the results in an abstract for a hypothetical clinical trial: a randomised trial. BMJ Open 2022;12:e056503.

Lindsley K, Fusco N, Li T, Scholten R, Hooft L. Clinical trial registration was associated with lower risk of bias compared with non-registered trials among trials included in systematic reviews. J Clin Epidemiol 2022;145:164-73.

Lunny C, Veroniki AA, Hutton B, White I, Higgins J, Wright JM, et al. Knowledge user survey and Delphi process to inform development of a new risk of bias tool to assess systematic reviews with network meta-analysis (RoB NMA tool). BMJ Evid Based Med 2022; bmjebm-2022-111944.

Minozzi S, Gonzalez-Lorenzo M, Cinquini M, Berardinelli D, Cagnazzo C, Ciardullo S, et al. Adherence of systematic reviews to Cochrane RoB2 guidance was frequently poor: a meta epidemiological study. J Clin Epidemiol 2022; doi: 10.1016/j.jclinepi.2022.09.003.

Nejstgaard CH, Lundh A, Abdi S, Clayton G, Gelle MHA, Laursen DRT, et al. Combining meta-epidemiological study datasets on commercial funding of randomised clinical trials: Database, methods, and descriptive results of the COMFIT study. Res Synth Methods 2022;13:214-28.

Parker L, Boughton S, Lawrence R, Bero L. Experts identified warning signs of fraudulent research: a qualitative study to inform a screening tool. J Clin Epidemiol 2022;151:1-17.

Former reading lists

The December 2021 reading list can be found here.

The March 2021 reading list can be found here.

The July 2020 reading list can be found here.

The December 2019 reading list can be found here.

The March 2019 reading list can be found here.

The August 2018 reading list can be found here.

The February 2018 reading list can be found here.